Cargando…
Modulation of the mevalonate pathway and cell growth by pravastatin and d-limonene in a human hepatoma cell line (Hep G2).
Modulation of cell growth by a combination of pravastatin [a 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor] and d-limonene (an inhibitor of protein isoprenylation) was studied using Hep G2, a human hepatoma-derived cell line. Pravastatin, at 0.1 mM, produced 85% inhibition of c...
Autores principales: | Kawata, S., Nagase, T., Yamasaki, E., Ishiguro, H., Matsuzawa, Y. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1969414/ https://www.ncbi.nlm.nih.gov/pubmed/8198962 |
Ejemplares similares
-
Effect of Pravastatin, a Potent 3‐Hydroxy‐3‐methylgliitaryl‐coenzyme A Reductase Inhibitor, on Survival of AH130 Hepatoma‐bearing Rats
por: Kawata, Sumio, et al.
Publicado: (1992) -
Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial
por: Kawata, S, et al.
Publicado: (2001) -
Pathways for the mutagenesis of 1-nitropyrene and dinitropyrenes in the human hepatoma cell line HepG2.
por: Silvers, K J, et al.
Publicado: (1994) -
microRNA-mediated resistance to hypoglycemia in the HepG2 human hepatoma cell line
por: Ueki, Satomi, et al.
Publicado: (2016) -
Transcriptional Tuning of Mevalonate Pathway Enzymes
to Identify the Impact on Limonene Production in Escherichia
coli
por: Shin, Jonghyeon, et al.
Publicado: (2022)